The Sidney Kimmel Comprehensive Cancer Center
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Lenalidomide and Vaccine Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 2
Completed
- Conditions
- Multiple Myeloma and Plasma Cell Neoplasm
- Interventions
- Biological: pneumococcal polyvalent vaccine
- First Posted Date
- 2007-03-09
- Last Posted Date
- 2015-08-24
- Target Recruit Count
- 22
- Registration Number
- NCT00445484
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
MRI in Evaluating the Effect of Efaproxiral on the Brain in Patients With Recurrent or Progressive Glioma Enrolled on Clinical Trial NABTT-9806
Not Applicable
Withdrawn
- Conditions
- Brain and Central Nervous System Tumors
- Interventions
- Device: magnetic resonance imaging (MRI)
MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell Carcinoma of the Head and Neck
Phase 1
Terminated
- Conditions
- Squamous Cell CarcinomaHead and Neck CancerResected Head and Neck CancerMucositis
Study of Image-guided Dosimetry for Interstitial Prostate Brachytherapy
Phase 1
Completed
- Conditions
- Locally Confined Adenocarcinoma of the Prostate
- First Posted Date
- 2007-01-25
- Last Posted Date
- 2012-11-14
- Target Recruit Count
- 6
- Registration Number
- NCT00426959
- Locations
- 🇺🇸
The Sidney Kimmel Comprehensive Cancer Center at The Johns Hopkins University, Baltimore, Maryland, United States
Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
Phase 2
Completed
- Conditions
- LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
- Interventions
- Biological: sargramostimGenetic: cytogenetic analysisGenetic: fluorescence in situ hybridizationOther: flow cytometryOther: laboratory biomarker analysisProcedure: biopsy
- First Posted Date
- 2007-01-23
- Last Posted Date
- 2018-10-05
- Target Recruit Count
- 26
- Registration Number
- NCT00425477
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Iodine I 131 in Treating Patients With Thyroid Cancer
Not Applicable
Terminated
- Conditions
- Head and Neck Cancer
- Interventions
- Device: Patient-specific dosimetry
- First Posted Date
- 2006-12-28
- Last Posted Date
- 2018-07-18
- Target Recruit Count
- 9
- Registration Number
- NCT00416949
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma
Completed
- Conditions
- Lymphoma
- Interventions
- Device: Patient-specific dosimetryDevice: conventional dosimetry
- First Posted Date
- 2006-12-28
- Last Posted Date
- 2018-08-27
- Target Recruit Count
- 9
- Registration Number
- NCT00416312
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Neo-adjuvant Chemotherapy in Locally Advanced Gastric Cancer
Phase 2
Completed
- Conditions
- Stage T3-4NxM0 Gastric Cancer
- Interventions
- First Posted Date
- 2006-12-21
- Last Posted Date
- 2019-07-25
- Target Recruit Count
- 18
- Registration Number
- NCT00414271
- Locations
- 🇸🇬
Johns Hopkins Singapore International Medical Center, Singapore, Singapore
Prospective Assessment of Symptoms and Quality of Life in Rectal Cancer Patients Receiving Chemo-Radiotherapy
Completed
- Conditions
- Rectal Cancer
- First Posted Date
- 2006-12-21
- Last Posted Date
- 2019-11-26
- Target Recruit Count
- 13
- Registration Number
- NCT00414232
- Locations
- 🇺🇸
The Sidney Kimmel Comprehensive Cancer Center at The Johns Hopkins University, Baltimore, Maryland, United States
Pattern of Cell Death Following Neoadjuvant Therapy for Metastatic Colon Cancer
Completed
- Conditions
- Metastatic Colorectal Cancer
- First Posted Date
- 2006-12-21
- Last Posted Date
- 2010-09-16
- Target Recruit Count
- 100
- Registration Number
- NCT00414492
- Locations
- 🇺🇸
Johns Hopkins Medicine, Baltimore, Maryland, United States
© Copyright 2025. All Rights Reserved by MedPath